CymaBay Therapeutics, Inc.

ADAGE CAPITAL PARTNERS GP, L.L.C.

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/14/2024

Shares

2,628,000

Value ($000)

62,073

Weight

0.1%

2019 Q4 - 2023 Q4 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/14/2024	62,073	0.1%	2,628,000	12/31/2023
2023 Q3	11/14/2023	61,504	0.1%	4,125,000	9/30/2023
2023 Q2	8/14/2023	48,194	0.1%	4,401,292	6/30/2023
2023 Q1	5/15/2023	38,363	0.1%	4,399,400	3/31/2023
2022 Q4	2/14/2023	3,135	0.0%	500,000	12/31/2022
2022 Q3	11/14/2022	1,750	0.0%	500,000	9/30/2022
2022 Q2	8/15/2022	1,475	0.0%	500,000	6/30/2022
2022 Q1	5/16/2022	4,665	0.0%	1,500,000	3/31/2022
2021 Q4	2/14/2022	4,901	0.0%	1,450,000	12/31/2021
2021 Q3	11/15/2021	5,293	0.0%	1,450,000	9/30/2021
2021 Q2	8/16/2021	6,322	0.0%	1,450,000	6/30/2021
2021 Q1	5/17/2021	6,583	0.0%	1,450,000	3/31/2021
2020 Q4	2/16/2021	8,323	0.0%	1,450,000	12/31/2020
2020 Q3	11/16/2020	10,498	0.0%	1,450,000	9/30/2020
2020 Q2	8/14/2020	8,725	0.0%	2,500,000	6/30/2020
2020 Q1	5/15/2020	2,220	0.0%	1,500,000	3/31/2020
2019 Q4	2/14/2020	2,940	0.0%	1,500,000	12/31/2019